Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 197

1.

Cortical excitability affects mood state in patients with idiopathic generalized epilepsies (IGEs).

Bolden LB, Griffis JC, Nenert R, Allendorfer JB, Szaflarski JP.

Epilepsy Behav. 2019 Jan;90:84-89. doi: 10.1016/j.yebeh.2018.11.001. Epub 2018 Dec 2.

PMID:
30517908
2.

The Highs and Lows of the Endocannabinoid System-Another Piece to the Epilepsy Puzzle?

Szaflarski JP.

Epilepsy Curr. 2018 Sep-Oct;18(5):315-317. doi: 10.5698/1535-7597.18.5.315. No abstract available.

3.

The US Food and Drug Administration's Authorization of the First Cannabis-Derived Pharmaceutical: Are We Out of the Haze?

Yang YT, Szaflarski JP.

JAMA Neurol. 2018 Nov 19. doi: 10.1001/jamaneurol.2018.3550. [Epub ahead of print] No abstract available.

PMID:
30452525
4.

Cortical excitability and seizure control influence attention performance in patients with idiopathic generalized epilepsies (IGEs).

Bolden LB, Griffis JC, Nenert R, Allendorfer JB, Szaflarski JP.

Epilepsy Behav. 2018 Dec;89:135-142. doi: 10.1016/j.yebeh.2018.10.026. Epub 2018 Nov 8.

PMID:
30415135
5.

Psychogenic Nonepileptic Seizures (PNES) as a Network Disorder - Evidence From Neuroimaging of Functional (Psychogenic) Neurological Disorders.

Szaflarski JP, LaFrance WC Jr.

Epilepsy Curr. 2018 Jul-Aug;18(4):211-216. doi: 10.5698/1535-7597.18.4.211. No abstract available.

6.

Bilateral independent periodic discharges are associated with electrographic seizures and poor outcome: A case-control study.

Osman G, Rahangdale R, Britton JW, Gilmore EJ, Haider HA, Hantus S, Herlopian A, Hocker SE, Woo Lee J, Legros B, Mendoza M, Punia V, Rampal N, Szaflarski JP, Wallace AD, Westover MB, Hirsch LJ, Gaspard N.

Clin Neurophysiol. 2018 Nov;129(11):2284-2289. doi: 10.1016/j.clinph.2018.07.025. Epub 2018 Aug 29.

PMID:
30227348
7.

Cannabis for the Treatment of Epilepsy: an Update.

Gaston TE, Szaflarski JP.

Curr Neurol Neurosci Rep. 2018 Sep 8;18(11):73. doi: 10.1007/s11910-018-0882-y. Review.

PMID:
30194563
8.

Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study.

Szaflarski JP, Bebin EM, Cutter G, DeWolfe J, Dure LS, Gaston TE, Kankirawatana P, Liu Y, Singh R, Standaert DG, Thomas AE, Ver Hoef LW; UAB CBD Program.

Epilepsy Behav. 2018 Oct;87:131-136. doi: 10.1016/j.yebeh.2018.07.020. Epub 2018 Aug 9.

9.

Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes.

Devinsky O, Verducci C, Thiele EA, Laux LC, Patel AD, Filloux F, Szaflarski JP, Wilfong A, Clark GD, Park YD, Seltzer LE, Bebin EM, Flamini R, Wechsler RT, Friedman D.

Epilepsy Behav. 2018 Sep;86:131-137. doi: 10.1016/j.yebeh.2018.05.013. Epub 2018 Jul 11.

10.

Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results.

Szaflarski JP, Bebin EM, Comi AM, Patel AD, Joshi C, Checketts D, Beal JC, Laux LC, De Boer LM, Wong MH, Lopez M, Devinsky O, Lyons PD, Zentil PP, Wechsler R; CBD EAP study group.

Epilepsia. 2018 Aug;59(8):1540-1548. doi: 10.1111/epi.14477. Epub 2018 Jul 12.

11.

Toward the "Fingerprint" of the Ictal Onset Zone - Is Mr. Morlet the Winner?

Szaflarski JP, Toth E.

Epilepsy Curr. 2018 May-Jun;18(3):158-159. doi: 10.5698/1535-7597.18.3.158. No abstract available.

12.

A feasibility study of combined intermittent theta burst stimulation and modified constraint-induced aphasia therapy in chronic post-stroke aphasia.

Szaflarski JP, Griffis J, Vannest J, Allendorfer JB, Nenert R, Amara AW, Sung V, Walker HC, Martin AN, Mark VW, Zhou X.

Restor Neurol Neurosci. 2018;36(4):503-518. doi: 10.3233/RNN-180812.

PMID:
29889086
13.

Affiliate stigma and caregiver burden in intractable epilepsy.

Hansen B, Szaflarski M, Bebin EM, Szaflarski JP.

Epilepsy Behav. 2018 Aug;85:1-6. doi: 10.1016/j.yebeh.2018.05.028. Epub 2018 Jun 7.

PMID:
29886019
14.

The Disruptive Nature of Focal Developmental Insults.

Szaflarski JP.

Epilepsy Curr. 2018 Jan-Feb;18(1):29-30. doi: 10.5698/1535-7597.18.1.29. No abstract available.

15.

Longitudinal fMRI study of language recovery after a left hemispheric ischemic stroke.

Nenert R, Allendorfer JB, Martin AM, Banks C, Vannest J, Holland SK, Hart KW, Lindsell CJ, Szaflarski JP.

Restor Neurol Neurosci. 2018;36(3):359-385. doi: 10.3233/RNN-170767.

PMID:
29782329
16.

Phase II Randomized Controlled Trial of Constraint-Induced Movement Therapy in Multiple Sclerosis. Part 2: Effect on White Matter Integrity.

Barghi A, Allendorfer JB, Taub E, Womble B, Hicks JM, Uswatte G, Szaflarski JP, Mark VW.

Neurorehabil Neural Repair. 2018 Mar;32(3):233-241. doi: 10.1177/1545968317753073.

PMID:
29668401
17.

How UV Light Touches the Brain and Endocrine System Through Skin, and Why.

Slominski AT, Zmijewski MA, Plonka PM, Szaflarski JP, Paus R.

Endocrinology. 2018 May 1;159(5):1992-2007. doi: 10.1210/en.2017-03230. Review.

PMID:
29546369
18.

Prognostic Value of EEG in Patients after Cardiac Arrest-An Updated Review.

Muhlhofer W, Szaflarski JP.

Curr Neurol Neurosci Rep. 2018 Mar 10;18(4):16. doi: 10.1007/s11910-018-0826-6. Review.

PMID:
29525975
19.

Risk of pharmacokinetic interactions between antiepileptic and other drugs in older persons and factors associated with risk.

Faught E, Szaflarski JP, Richman J, Funkhouser E, Martin RC, Piper K, Dai C, Juarez L, Pisu M.

Epilepsia. 2018 Mar;59(3):715-723. doi: 10.1111/epi.14010. Epub 2018 Feb 7.

PMID:
29411348
20.

An interaction between warfarin and cannabidiol, a case report.

Grayson L, Vines B, Nichol K, Szaflarski JP; UAB CBD Program.

Epilepsy Behav Case Rep. 2017 Oct 12;9:10-11. doi: 10.1016/j.ebcr.2017.10.001. eCollection 2018.

21.

Facial emotion processing in patients with seizure disorders.

Szaflarski JP, Allendorfer JB, Nenert R, LaFrance WC Jr, Barkan HI, DeWolfe J, Pati S, Thomas AE, Ver Hoef L.

Epilepsy Behav. 2018 Feb;79:193-204. doi: 10.1016/j.yebeh.2017.12.004. Epub 2018 Jan 6.

PMID:
29309953
22.

Racial disparities in temporal lobe epilepsy.

Allen SE, Limdi N, Westrick AC, Ver Hoef LW, Szaflarski JP, Knowlton RC.

Epilepsy Res. 2018 Feb;140:56-60. doi: 10.1016/j.eplepsyres.2017.12.012. Epub 2017 Dec 16.

PMID:
29272743
23.

The 'Thalamic Hubness' of Anterior Temporal Lobectomy Outcome.

Szaflarski JP.

Epilepsy Curr. 2017 Sep-Oct;17(5):283-284. doi: 10.5698/1535-7597.17.5.283. No abstract available.

24.

Dysfunction in emotion processing underlies functional (psychogenic) dystonia.

Espay AJ, Maloney T, Vannest J, Norris MM, Eliassen JC, Neefus E, Allendorfer JB, Chen R, Szaflarski JP.

Mov Disord. 2018 Jan;33(1):136-145. doi: 10.1002/mds.27217. Epub 2017 Nov 10.

25.

Impaired emotion processing in functional (psychogenic) tremor: A functional magnetic resonance imaging study.

Espay AJ, Maloney T, Vannest J, Norris MM, Eliassen JC, Neefus E, Allendorfer JB, Lang AE, Szaflarski JP.

Neuroimage Clin. 2017 Oct 18;17:179-187. doi: 10.1016/j.nicl.2017.10.020. eCollection 2018.

26.

The use of cannabidiol for seizure management in patients with brain tumor-related epilepsy.

Warren PP, Bebin EM, Nabors LB, Szaflarski JP.

Neurocase. 2017 Oct - Dec;23(5-6):287-291. doi: 10.1080/13554794.2017.1391294. Epub 2017 Oct 24.

PMID:
29063814
27.

Linking left hemispheric tissue preservation to fMRI language task activation in chronic stroke patients.

Griffis JC, Nenert R, Allendorfer JB, Szaflarski JP.

Cortex. 2017 Nov;96:1-18. doi: 10.1016/j.cortex.2017.08.031. Epub 2017 Sep 5.

28.

Relationship Between Alpha Rhythm and the Default Mode Network: An EEG-fMRI Study.

Bowman AD, Griffis JC, Visscher KM, Dobbins AC, Gawne TJ, DiFrancesco MW, Szaflarski JP.

J Clin Neurophysiol. 2017 Nov;34(6):527-533. doi: 10.1097/WNP.0000000000000411.

PMID:
28914659
29.

Age-related language lateralization assessed by fMRI: The effects of sex and handedness.

Nenert R, Allendorfer JB, Martin AM, Banks C, Vannest J, Holland SK, Szaflarski JP.

Brain Res. 2017 Nov 1;1674:20-35. doi: 10.1016/j.brainres.2017.08.021. Epub 2017 Aug 19.

PMID:
28830770
30.

Author response: Practice guideline summary: Use of fMRI in the presurgical evaluation of patients with epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Gloss D, Szaflarski JP, Holland SK, Binder JR, Theodore WH.

Neurology. 2017 Aug 8;89(6):640-641. doi: 10.1212/WNL.0000000000004203. No abstract available.

PMID:
28784637
31.

Interactions between cannabidiol and commonly used antiepileptic drugs.

Gaston TE, Bebin EM, Cutter GR, Liu Y, Szaflarski JP; UAB CBD Program.

Epilepsia. 2017 Sep;58(9):1586-1592. doi: 10.1111/epi.13852. Epub 2017 Aug 6.

32.

Neuroimaging Correlates of Post-Stroke Aphasia Rehabilitation in a Pilot Randomized Trial of Constraint-Induced Aphasia Therapy.

Nenert R, Allendorfer JB, Martin AM, Banks C, Ball A, Vannest J, Dietz AR, Szaflarski JP.

Med Sci Monit. 2017 Jul 18;23:3489-3507.

33.

Connectomics 2.0: Connected or Not, Is This the Question?

Szaflarski JP.

Epilepsy Curr. 2017 May-Jun;17(3):155-156. doi: 10.5698/1535-7511.17.3.155. No abstract available.

34.

The Man Versus the Machine: The Machine Wins the Race to Detect the Scalp-Negative Seizures.

Szaflarski JP.

Epilepsy Curr. 2017 May-Jun;17(3):142-143. doi: 10.5698/1535-7511.17.3.142. No abstract available.

35.

Post-traumatic epilepsy associations with mental health outcomes in the first two years after moderate to severe TBI: A TBI Model Systems analysis.

Juengst SB, Wagner AK, Ritter AC, Szaflarski JP, Walker WC, Zafonte RD, Brown AW, Hammond FM, Pugh MJ, Shea T, Krellman JW, Bushnik T, Arenth PM.

Epilepsy Behav. 2017 Aug;73:240-246. doi: 10.1016/j.yebeh.2017.06.001. Epub 2017 Jun 26.

36.

Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial.

Berg M, Welty TE, Gidal BE, Diaz FJ, Krebill R, Szaflarski JP, Dworetzky BA, Pollard JR, Elder EJ Jr, Jiang W, Jiang X, Switzer RD, Privitera MD.

JAMA Neurol. 2017 Aug 1;74(8):919-926. doi: 10.1001/jamaneurol.2017.0497.

37.

Cortical excitability and neuropsychological functioning in healthy adults.

Bolden LB, Griffis JC, Pati S, Szaflarski JP.

Neuropsychologia. 2017 Jul 28;102:190-196. doi: 10.1016/j.neuropsychologia.2017.06.028. Epub 2017 Jun 23.

PMID:
28648572
38.

Magnetoencephalography and Stereo-EEG Unite!

Szaflarski JP.

Epilepsy Curr. 2017 Mar-Apr;17(2):86-87. doi: 10.5698/1535-7511.17.2.86. No abstract available.

39.

Quality of Antiepileptic Treatment Among Older Medicare Beneficiaries With Epilepsy: A Retrospective Claims Data Analysis.

Pisu M, Richman J, Piper K, Martin R, Funkhouser E, Dai C, Juarez L, Szaflarski JP, Faught E.

Med Care. 2017 Jul;55(7):677-683. doi: 10.1097/MLR.0000000000000724.

40.

Quality Indicator for Epilepsy Treatment 15 (QUIET-15): Intervening after recurrent seizures in the elderly.

Szaflarski JP, Martin RC, Faught E, Funkhouser E, Richman J, Piper K, Juarez L, Dai C, Pisu M.

Epilepsy Behav. 2017 May;70(Pt A):253-258. doi: 10.1016/j.yebeh.2017.03.007. Epub 2017 Apr 12.

41.

Damage to white matter bottlenecks contributes to language impairments after left hemispheric stroke.

Griffis JC, Nenert R, Allendorfer JB, Szaflarski JP.

Neuroimage Clin. 2017 Feb 24;14:552-565. doi: 10.1016/j.nicl.2017.02.019. eCollection 2017.

42.

Neuroimaging in Epilepsy.

Middlebrooks EH, Ver Hoef L, Szaflarski JP.

Curr Neurol Neurosci Rep. 2017 Apr;17(4):32. doi: 10.1007/s11910-017-0746-x. Review.

PMID:
28324301
43.

Social correlates of health status, quality of life, and mood states in patients treated with cannabidiol for epilepsy.

Szaflarski M, Hansen B, Bebin EM, Szaflarski JP.

Epilepsy Behav. 2017 May;70(Pt B):364-369. doi: 10.1016/j.yebeh.2016.12.033. Epub 2017 Feb 21.

PMID:
28236578
44.

Photosensitivity in generalized epilepsies.

Poleon S, Szaflarski JP.

Epilepsy Behav. 2017 Mar;68:225-233. doi: 10.1016/j.yebeh.2016.10.040. Epub 2017 Feb 16. Review.

PMID:
28215998
45.

Cannabinoids and epilepsy - Introduction.

Szaflarski JP, Devinsky O.

Epilepsy Behav. 2017 May;70(Pt B):277. doi: 10.1016/j.yebeh.2017.01.015. Epub 2017 Feb 16. No abstract available.

PMID:
28215997
46.

Changes in functional organization and functional connectivity during story listening in children with benign childhood epilepsy with centro-temporal spikes.

Vannest J, Maloney TC, Tenney JR, Szaflarski JP, Morita D, Byars AW, Altaye M, Holland SK, Glauser TA.

Brain Lang. 2017 Feb 13. pii: S0093-934X(15)30140-1. doi: 10.1016/j.bandl.2017.01.009. [Epub ahead of print]

47.

What does the U.S. Medicare administrative claims database tell us about initial antiepileptic drug treatment for older adults with new-onset epilepsy?

Martin RC, Faught E, Szaflarski JP, Richman J, Funkhouser E, Piper K, Juarez L, Dai C, Pisu M.

Epilepsia. 2017 Apr;58(4):548-557. doi: 10.1111/epi.13675. Epub 2017 Feb 7.

48.

Continuous Electroencephalography (cEEG) Monitoring and Outcomes of Critically Ill Patients.

Khawaja AM, Wang G, Cutter GR, Szaflarski JP.

Med Sci Monit. 2017 Feb 4;23:649-658.

49.

Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy.

Allendorfer JB, Szaflarski JP.

Epilepsy Behav. 2017 May;70(Pt B):349-354. doi: 10.1016/j.yebeh.2016.11.020. Epub 2017 Jan 18. Review.

PMID:
28109780
50.

Practice guideline summary: Use of fMRI in the presurgical evaluation of patients with epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Szaflarski JP, Gloss D, Binder JR, Gaillard WD, Golby AJ, Holland SK, Ojemann J, Spencer DC, Swanson SJ, French JA, Theodore WH.

Neurology. 2017 Jan 24;88(4):395-402. doi: 10.1212/WNL.0000000000003532. Epub 2017 Jan 11.

Supplemental Content

Loading ...
Support Center